Syra Health Seeks Shareholder Approval for 34% Equity Incentive Plan Increase
SYRA has more than doubled off its 52-week low of $0.052 on light trading volume (0.1× avg).
Summary
Syra Health Corp. filed definitive proxy materials for its annual meeting, seeking shareholder approval to significantly increase its equity incentive plan by 4.1 million shares, representing a potential dilution of over 34%.
Key Events · Corporate Governance and Compliance · SYRA
-
Annual Meeting Scheduled
The Annual Meeting of Stockholders is scheduled for July 23, 2026, to consider several proposals.
-
Significant Equity Plan Increase Proposed
Shareholders will vote on amending the 2022 Omnibus Equity Incentive Plan to increase the number of Class A shares available for issuance to 4,100,000. This represents a potential dilution of approximately 34.3% of current outstanding shares.
-
Director Elections
Shareholders will vote on the election of five directors to the Board.
-
Auditor Ratification
The appointment of M&K CPAS, PLLC as the independent registered public accounting firm for fiscal year 2026 will be put to a shareholder vote.
Analysis · SYRA · Trade & Services
Syra Health Corp. is asking shareholders to approve a significant increase in its equity incentive plan, adding 4.1 million Class A shares. This represents a potential dilution of over 34% of the company's current outstanding shares. For a micro-cap company that recently achieved its first profitable quarter but previously faced 'going concern' doubts, such a substantial authorization for future share issuance creates a significant overhang and could impact shareholder value through dilution, even if it provides flexibility for compensation or future capital needs.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SYRA was trading at $0.50 on OTC in the Trade & Services sector, with a market capitalization of approximately $6M. The 52-week trading range was $0.05 to $0.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.